Stem Cell Therapy Aids Walking

This is a US news story, published by MailOnline, that relates primarily to * Jennifer news.

US news

For more US news, you can click here:

more US news

* Jennifer news

For more * Jennifer news, you can click here:

more * Jennifer news

medical innovations news

For more medical innovations news, you can click here:

more medical innovations news

MailOnline news

For more news from MailOnline, you can click here:

more news from MailOnline

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about

stem cell therapy

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest regular knee pain news, stem cell therapies news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

stem cell treatments

MailOnline

•

Health

A cheap miracle therapy helped me walk again and ended my agony

Summary

Nutrition label

77% Informative

Jennifer , now 68 , hadn't walked without pain in years after retiring from the NYPD and federal government.

The wear and tear of being a first responder left her with rapidly deteriorating cartilage in retirement.

Stem cells are the most basic cell with the ability to become any kind of specialized cell.

Despite being more affordable than some out-of-pocket surgeries, stem cell therapy can still cost between $1,500 and $8,000 per injection - which is not covered by insurance.

Most stem cell-based regenerative treatments are still considered experimental by the FDA , forcing them into clinical trials to evaluate safety and efficacy.

The Right to Try Act, passed in 2018 , allows terminally ill patients to access experimental treatments like regenerative stem cell therapies.

The FDA won a federal case against US Stem Cell, Inc, after documenting rare instances where patients were injured during stem cell treatments, including three cases that led to blindness from unapproved retinal treatments.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful